These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 27803375
1. Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs. Macfarlane L, Parkin T, Ramsey I. Vet Rec; 2016 Dec 10; 179(23):597. PubMed ID: 27803375 [Abstract] [Full Text] [Related]
2. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane. Sieber-Ruckstuhl NS, Boretti FS, Wenger M, Maser-Gluth C, Reusch CE. Domest Anim Endocrinol; 2006 Jul 10; 31(1):63-75. PubMed ID: 16233969 [Abstract] [Full Text] [Related]
3. Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilostane treatment. Boretti FS, Holzthüm J, Reusch CE, Sieber-Ruckstuhl NS. Schweiz Arch Tierheilkd; 2016 Sep 10; 158(9):631-638. PubMed ID: 27655162 [Abstract] [Full Text] [Related]
4. Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs. Bell R, Neiger R, McGrotty Y, Ramsey IK. Vet Rec; 2006 Aug 26; 159(9):277-81. PubMed ID: 16946310 [Abstract] [Full Text] [Related]
5. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism. Griebsch C, Lehnert C, Williams GJ, Failing K, Neiger R. J Vet Intern Med; 2014 Aug 26; 28(1):160-5. PubMed ID: 24341822 [Abstract] [Full Text] [Related]
11. Comparison of methods to monitor dogs with hypercortisolism treated with trilostane. Golinelli S, de Marco V, Leal RO, Barbarossa A, Aniballi C, Maietti E, Tardo AM, Galac S, Fracassi F. J Vet Intern Med; 2021 Nov 26; 35(6):2616-2627. PubMed ID: 34672018 [Abstract] [Full Text] [Related]
15. The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism. Oda H, Mori A, Shono S, Onozawa E, Sako T. J Vet Med Sci; 2016 Jun 01; 78(5):851-4. PubMed ID: 26782012 [Abstract] [Full Text] [Related]
16. Adrenocorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy. Witt AL, Neiger R. Vet Rec; 2004 Mar 27; 154(13):399-400. PubMed ID: 15083974 [No Abstract] [Full Text] [Related]
18. Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Arenas Bermejo C, Pérez Alenza D, García San José P, Llauet L, Pérez-López L, Melián C, C Feldman E. J Vet Intern Med; 2020 Jul 27; 34(4):1413-1422. PubMed ID: 32533623 [Abstract] [Full Text] [Related]
19. Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism. Aldridge C, Behrend EN, Kemppainen RJ, Lee-Fowler TM, Martin LG, Ward CR, Bruyette D, Pannu J, Gaillard P, Lee HP. J Vet Intern Med; 2016 Sep 27; 30(5):1637-1641. PubMed ID: 27425787 [Abstract] [Full Text] [Related]
20. Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008-2012). Woolcock AD, Bugbee AC, Creevy KE. J Am Vet Med Assoc; 2016 Apr 01; 248(7):814-21. PubMed ID: 27003023 [Abstract] [Full Text] [Related] Page: [Next] [New Search]